Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study

Thorax. 2021 Sep;76(9):939-941. doi: 10.1136/thoraxjnl-2020-216526. Epub 2021 Mar 29.

Abstract

Non-pharmaceutical interventions (NPIs) have been widely implemented to mitigate the spread of COVID-19. We assessed the effect of NPIs on hospitalisations for pneumonia, influenza, COPD and asthma. This retrospective, ecological study compared the weekly incidence of hospitalisation for four respiratory conditions before (January 2016-January 2020) and during (February-July 2020) the implementation of NPI against COVID-19. Hospitalisations for all four respiratory conditions decreased substantially during the intervention period. The cumulative incidence of admissions for COPD and asthma was 58% and 48% of the mean incidence during the 4 preceding years, respectively.

Keywords: COVID-19; respiratory infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administrative Claims, Healthcare / statistics & numerical data
  • Asthma / epidemiology*
  • COVID-19 / prevention & control*
  • Humans
  • Influenza, Human / epidemiology*
  • Patient Admission / statistics & numerical data*
  • Pulmonary Disease, Chronic Obstructive / epidemiology*
  • Republic of Korea / epidemiology
  • Retrospective Studies
  • SARS-CoV-2